Cargando…
Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)
To better understand the etiology of inflammatory breast cancer (IBC) and identify potential therapies, we studied genomic alterations in IBC patients. Targeted, next-generation sequencing (NGS) was performed on cell-free DNA (cfDNA) (n = 33) and paired DNA from tumor tissues (n = 29) from 32 IBC pa...
Autores principales: | Gong, Yulan, Nagarathinam, Rajeswari, Arisi, Maria F., Gerratana, Lorenzo, Winn, Jennifer S., Slifker, Michael, Pei, Jianming, Cai, Kathy Q., Hasse, Zachary, Obeid, Elias, Noriega, Julio, Sebastiano, Christopher, Ross, Eric, Alpaugh, Katherine, Cristofanilli, Massimo, Fernandez, Sandra V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396191/ https://www.ncbi.nlm.nih.gov/pubmed/34445631 http://dx.doi.org/10.3390/ijms22168924 |
Ejemplares similares
-
Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013) -
Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer
por: Winn, Jennifer S., et al.
Publicado: (2020) -
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
por: Devi, Gayathri R., et al.
Publicado: (2019) -
Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
por: Fernandez, Sandra V., et al.
Publicado: (2020) -
Select agent program impact on the IBC
por: Adamovicz, Jeffery
Publicado: (2016)